Literature DB >> 10694819

Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer.

T Stöver1, M Yagi, Y Raphael.   

Abstract

Cochlear gene transfer is a promising new approach for inner ear therapy. Previous studies have demonstrated hair cell protection with cochlear gene transfer not only in the inoculated, but also in the uninoculated ear. To characterize the kinetics of viral spread, we investigated the extent of transgene expression in the contralateral (uninoculated) cochlea after unilateral adenoviral cochlear gene transfer. We used a lacZ reporter gene vector, and demonstrated spread of the adenovirus into the cerebrospinal fluid (CSF) after cochlear inoculation of 25 microl viral vector. Direct virus application into the CSF resulted in transduction of both cochleae, whereas virus inoculation into the bloodstream did not. The cochlear aqueduct was identified as the most likely route of virus spread to the contralateral cochlea. These data enhance our understanding of the kinetics of virus-mediated transgene expression in the inner ear, and assist in the development of clinical applications for inner ear gene therapy. Our results showed a functional communication between the CSF and the perilymphatic space of the inner ear, that is not only of importance for otological gene transfer, but also for CNS gene transfer. Gene Therapy (2000) 7, 377-383.

Mesh:

Year:  2000        PMID: 10694819     DOI: 10.1038/sj.gt.3301108

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  32 in total

1.  Murine intracochlear drug delivery: reducing concentration gradients within the cochlea.

Authors:  David A Borkholder; Xiaoxia Zhu; Brad T Hyatt; Alfredo S Archilla; William J Livingston; Robert D Frisina
Journal:  Hear Res       Date:  2010-05-06       Impact factor: 3.208

Review 2.  Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system.

Authors:  Lisa N Pettingill; Rachael T Richardson; Andrew K Wise; Stephen J O'Leary; Robert K Shepherd
Journal:  IEEE Trans Biomed Eng       Date:  2007-06       Impact factor: 4.538

Review 3.  [Protection and regeneration of sensory epithelia of the inner ear].

Authors:  S Pfannenstiel; M Praetorius
Journal:  HNO       Date:  2008-01       Impact factor: 1.284

Review 4.  Current status and prospects of gene therapy for the inner ear.

Authors:  Hong Sun; Aji Huang; Shousong Cao
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

5.  Chronic neurotrophin delivery promotes ectopic neurite growth from the spiral ganglion of deafened cochleae without compromising the spatial selectivity of cochlear implants.

Authors:  Thomas G Landry; James B Fallon; Andrew K Wise; Robert K Shepherd
Journal:  J Comp Neurol       Date:  2013-08-15       Impact factor: 3.215

6.  The spread of adenoviral vectors to central nervous system through pathway of cochlea in mimetic aging and young rats.

Authors:  X Chen; X Zhao; Y Hu; F Lan; H Sun; G Fan; Y Sun; J Wu; W Kong; W Kong
Journal:  Gene Ther       Date:  2015-06-30       Impact factor: 5.250

7.  Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons.

Authors:  Rachael T Richardson; Andrew K Wise; Brianna C Thompson; Brianna O Flynn; Patrick J Atkinson; Nicole J Fretwell; James B Fallon; Gordon G Wallace; Rob K Shepherd; Graeme M Clark; Stephen J O'Leary
Journal:  Biomaterials       Date:  2009-01-29       Impact factor: 12.479

8.  Optimizing atoh1-induced vestibular hair cell regeneration.

Authors:  Hinrich Staecker; Christina Schlecker; Shannon Kraft; Mark Praetorius; Chi Hsu; Douglas E Brough
Journal:  Laryngoscope       Date:  2014-06-17       Impact factor: 3.325

Review 9.  Gene therapy in the inner ear using adenovirus vectors.

Authors:  Jacob Husseman; Yehoash Raphael
Journal:  Adv Otorhinolaryngol       Date:  2009-06-02

10.  Gene transfer using bovine adeno-associated virus in the guinea pig cochlea.

Authors:  S B Shibata; G Di Pasquale; S R Cortez; J A Chiorini; Y Raphael
Journal:  Gene Ther       Date:  2009-05-21       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.